查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197758

核甘酸市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Nucleotides Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计在预测期内（2022 年至 2027 年），核甘酸市场的复合年增长率将超过 7%。

COVID-19 大流行对市场产生了积极影响，因为核甘酸在病毒性疾病的治疗中得到了主要应用。

推动市场发展的主要因素是药品对核甘酸的需求不断增加。 另一方面，对水产饲料行业的渗透有限阻碍了市场增长。

在预测期内，药用核甘酸预计将主导市场。

由于美国和加拿大等国家/地区的消费量不断增加，北美地区是最大的市场，预计在预测期内将成为增长最快的市场。

核甘酸市场趋势

食品和饲料添加剂领域有望主导市场

核甘酸在营养和生理功能中起着重要作用。 肌甘一磷酸（IMP）和鸟甘一磷酸（GMP）被广泛用作食品中的适口性增强剂。 因此，核甘酸可以改善饲料的适口性。

此外，核甘酸影响肠上皮细胞的恢復，具有增强免疫力的作用。 参与免疫的组织细胞不能自我合成核甘酸。 因此，摄入核甘酸可以增强免疫力。

动物疾病的增加需要保持牲畜足够的代谢率。 该行业的消费者意识也在不断增强，这增加了对动物饲料的需求。

根据国际饲料工业联合会的数据，全球复合饲料产量估计为每年 10 亿吨。 全球商业饲料製造业的年销售额估计超过 4000 亿美元。

联合国粮食及农业组织 (FAO) 估计，到 2050 年全球粮食产量将增加 60%，动物蛋白产量预计将进一步增加 - 到 2050 年肉类（家禽、猪肉和牛肉）将成为预计将翻一番，而奶製品和鱼类产量预计将增长近两倍。

因此，鑑于上述情况，预计食品和动物饲料添加剂领域将在预测期内主导市场。

中国有望主导亚太市场

中国是世界第二大医药市场。 由于中产阶级的壮大、人口老龄化、收入的增加和城市化进程的推进，中国的医药市场正在迅速崛起。

到 2022 年底，该国的医药销售额预计将达到 1750 亿美元。 预计这将促进其在製药行业使用方面研究的市场增长。

中国政府颁布了“健康中国 2030”蓝图，表明其继续将健康作为可持续社会和经济发展的先决条件。 由于该国积极的药物研究，预计在预测期内对核甘酸的需求也将增加。

此外，COVID-19 大流行增加了该国的药品需求和生产。 由于COVID-19疫情的影响，世界需要来自中国的药品。

近年来，随着饮食转向动物蛋白，中国的畜牧业发展迅速。 今天，中国是世界上最大的畜牧生产国和最大的饲料生产国。

因此，从上述方面来看，中国有望在预测期内（2022-2027）主导亚太市场。

核甘酸市场竞争者分析

核甘酸市场高度整合，顶级参与者占据市场主导份额。 顶级公司约占总市场份额的80%。 市场上的主要参与者（排名不分先后）包括 CJ CheilJedang Corp.、Ajinomoto Co., Ltd.、Thermo Fisher Scientific Inc.、DAESANG、STAR LAKE BIOSCIENCE 等。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 3 个月的分析师支持

内容

第一章介绍

  • 调查先决条件
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 司机
    • 製药行业对核甘酸的需求不断增长
    • 其他司机
  • 约束因素
    • 对鱼饲料行业的渗透有限
  • 工业价值链分析
  • 波特的五力分析
    • 新进入者的威胁
    • 买家的议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争程度

第 5 章市场细分

  • 氮基
    • 嘧啶
    • 嘌呤体
  • 用法
    • 医药
    • 食品和饲料添加剂
    • 药物发现
  • 地区
    • 亚太地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 其他亚太地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 其他欧洲
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲
    • 中东
      • 沙特阿拉伯
      • 南非
      • 其他中东地区

第六章竞争格局

  • 併购、合资企业、合作、合同
  • 市场份额 (%)**/排名分析
  • 主要参与者采用的策略
  • 公司简介
    • Ajinomoto Co. Inc.
    • CJ CHEILJEDANG CORP.
    • DAESANG
    • exoticbiosolutions.com
    • Jena Bioscience GmbH
    • MEIHUA HOLDINGS GROUP CO. LTD
    • Meridian
    • STAR LAKE BIOSCIENCE
    • Thermo Fisher Scientific Inc.

第七章市场机会与未来趋势

  • 核甘酸补充剂在肉鸡饲料中的用途
简介目录
Product Code: 71043

The nucleotides market is expected to register a CAGR of over 7% during the forecast period (2022-2027).

The impact of the COVID-19 pandemic was positive on the market, as nucleotides find major applications in treating viral diseases.

The major factor driving the market is the growing demand for nucleotides from pharmaceuticals. On the flip side, the limited penetration into the aquafeed industry is hindering the growth of the market.

Nucleotides from pharmaceutical applications are expected to dominate the market studied over the forecast period.

The North American region represents the largest market, and it is also expected to be the fastest-growing market over the forecast period, owing to the increasing consumption from countries like the United States and Canada.

Nucleotides Market Trends

The Food and Animal Feed Additives Segment is Expected to Dominate the Market

Nucleotides are vital in terms of nutritional and physiological functions. Inosine monophosphate (IMP) and guanosine monophosphate (GMP) are widely used as palatability enhancers in food. This helps nucleotides to enhance palatability for feed.

Also, nucleotides affect the recovery of intestinal epithelial cells, which helps boost immunity. Tissue cells involved in immunity cannot self synthesize nucleotides. Thus, immunity is strengthened by dietary nucleotides.

The rising incidences of animal diseases require maintaining adequate metabolism rates in livestock. Consumer awareness has also grown in this segment, which has increased the demand for animal feed.​

According to the International Feed Industry Federation, global compound feed production has reached an estimated 1 billion ton annually. Global commercial feed manufacturing generates an estimated annual turnover of over USD 400 billion. ​

The UN Food and Agricultural Organisation (FAO) estimates that the world will have to produce 60% more food by 2050, and it is believed that animal protein production will grow even more - meats (poultry/swine/beef) will double, and dairy and fish production will almost triple by 2050.

Hence, based on the aforementioned aspects, the food and animal feed additives segment is expected to dominate the market during the forecast period.

China is Expected to Dominate the Asia-Pacific Market

China is the second-largest market for pharmaceuticals globally. The market for pharmaceuticals is emerging rapidly due to the growing middle-class and aging population in the country, rising incomes, and increasing urbanization.

The pharmaceutical sales of the country are expected to reach up to USD 175 billion by the end of 2022. This is expected to boost the growth of the market studied in terms of its usage in the pharmaceutical industry.

The Chinese government promulgated Healthy China 2030, which is a blueprint outlining its ongoing intent to prioritize health as a precondition for sustained social and economic development. Additionally, the growing research in pharmaceuticals in the country is also expected to augment the demand for nucleotides during the forecast period.

Additionally, owing to the COVID-19 pandemic, the demand for and production of pharmaceuticals have increased in the country. The world is in need of pharmaceuticals from China due to the impact caused by the COVID-19 pandemic.

China's livestock industry has expanded rapidly in recent years as diets shift toward more animal proteins. At present, China is the world's largest producer of livestock products and the largest manufacturer of animal feed.

Hence, based on the aforementioned aspects, China is expected to dominate the Asia-Pacific market during the forecast period (2022-2027).

Nucleotides Market Competitor Analysis

The nucleotide market is highly consolidated, with the top players holding the lion's share in the market. The top players account for a share of around 80% of the total market. The key players in the market (in no particular order) include CJ CheilJedang Corp., Ajinomoto Co. Inc., Thermo Fisher Scientific Inc., DAESANG, and STAR LAKE BIOSCIENCE, among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Growing Demand for Nucleotides from the Pharmaceutical Industry
    • 4.1.2 Other Drivers
  • 4.2 Restraints
    • 4.2.1 Limited Penetration into the Aquafeed Industry
  • 4.3 Industry Value Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION

  • 5.1 Nitrogeneous Base
    • 5.1.1 Pyrimidine
    • 5.1.2 Purine
  • 5.2 Application
    • 5.2.1 Pharmaceutical
    • 5.2.2 Food and Animal Feed Additives
    • 5.2.3 Drug Discovery
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
      • 5.3.1.1 China
      • 5.3.1.2 India
      • 5.3.1.3 Japan
      • 5.3.1.4 South Korea
      • 5.3.1.5 Rest of Asia-Pacific
    • 5.3.2 North America
      • 5.3.2.1 United States
      • 5.3.2.2 Canada
      • 5.3.2.3 Mexico
    • 5.3.3 Europe
      • 5.3.3.1 Germany
      • 5.3.3.2 United Kingdom
      • 5.3.3.3 France
      • 5.3.3.4 Italy
      • 5.3.3.5 Rest of Europe
    • 5.3.4 South America
      • 5.3.4.1 Brazil
      • 5.3.4.2 Argentina
      • 5.3.4.3 Rest of South America
    • 5.3.5 Middle-East
      • 5.3.5.1 Saudi Arabia
      • 5.3.5.2 South Africa
      • 5.3.5.3 Rest of Middle-East

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share(%)**/Ranking Analysis
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Ajinomoto Co. Inc.
    • 6.4.2 CJ CHEILJEDANG CORP.
    • 6.4.3 DAESANG
    • 6.4.4 exoticbiosolutions.com
    • 6.4.5 Jena Bioscience GmbH
    • 6.4.6 MEIHUA HOLDINGS GROUP CO. LTD
    • 6.4.7 Meridian
    • 6.4.8 STAR LAKE BIOSCIENCE
    • 6.4.9 Thermo Fisher Scientific Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Application of Nucleotide Supplements in Broiler Chicken Diets